首页> 外国专利> METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING LOZARTAN IN COMPLEX WITH ADMIXTURE OF SOLUTIONS OF HOMEOPATHIC DELUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO ENDOTHELIAL SYNTHASE OF HUMAN NITROGEN OXIDE-C12, C30, C200

METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING LOZARTAN IN COMPLEX WITH ADMIXTURE OF SOLUTIONS OF HOMEOPATHIC DELUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO ENDOTHELIAL SYNTHASE OF HUMAN NITROGEN OXIDE-C12, C30, C200

机译:洛沙坦与多克隆抗体对人一氧化氮内皮细胞合成酶的顺势疗法解决方案的混合使用,以纠正血管内皮功能障碍的方法-C12,C30,C200

摘要

FIELD: medicine.;SUBSTANCE: for correction of endothelial dysfunction in experiment to white rats to males of line Wistar with endothelial dysfunction, against its modelling by intraperitoneal introduction of an inhibitor endothelial synthase "M-nitro-L-arginine of methyl ether in a dose of 25 mg/kg within 7-days enter intragastrically lozartan in a dose of 6 mg/kg daily and an admixture of homeopathic solutions in delution of polyclonal rabbit antibodies to endothelial synthase of human nitrogen oxide - C12, C30, C200 addition into drinking bowls to drink.;EFFECT: effective correction of endothelial dysfunction.;1 ex, 2 tbl
机译:领域:药物:用于纠正实验性白鼠对具有内皮功能障碍的Wistar系雄性大鼠的内皮功能障碍,反对通过腹膜内引入抑制剂内皮合酶“甲基醚的M-硝基-L-精氨酸25毫克/千克的剂量在7天之内进入胃内洛沙坦,剂量为每天6毫克/千克,并加入顺势疗法溶液稀释多克隆兔抗人氮氧化物内皮合酶抗体-C12,C30,C200加入饮用效果:有效纠正内皮功能障碍。1ex,2 tbl

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号